In primary brain tumors, glioma CIMP (G-CIMP) is highly associated with mutations in genes encoding isocitrate dehydrogenase (IDH1/2), and the IDH mutation, when overexpressed in normal astrocytes, can recapitulate the G-CIMP hypermethylation pattern (6–8). Here, IDH2 is linked to central nervous system cancer.